KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,605,800 | $20,442,000 | 6.86% |
| Baupost Group | 22,380,200 | $284,900,000 | 4.79% |
| Camber Capital Management LP | 3,000,000 | $38,190,000 | 2.73% |
| 1492 Capital Management LLC | 278,885 | $3,550,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 3,825,256 | $48,696,000 | 1.85% |
| Cormorant Asset Management, LP | 826,000 | $10,515,000 | 1.62% |
| Tamarack Capital Management, LLC | 950,000 | $12,094,000 | 1.59% |
| OAK RIDGE INVESTMENTS LLC | 3,286,844 | $41,841,000 | 0.94% |
| Knoll Capital Management, LLC | 200,000 | $2,546,000 | 0.74% |
| FALCON POINT CAPITAL, LLC | 69,689 | $887,000 | 0.69% |